Clinical trials show GLP-1 agonists reduce appetite signaling through the hypothalamus and increase satiety hormones, creating meaningful metabolic changes
In bacteria, the theta class GSTs includes all of the currently known bacterial glutathione transferases
Prescription reserved for specialists (endocrinology, nutrition) Saxenda (liraglutide) Daily injection Indicated for weight control in obese adults Progressive effect on satiety and blood sugar levels Requires close medical supervision to adjust doses Saxenda is no longer available
Accessed: Jun
The SELECT trial showed that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in people with overweight or obesity and established cardiovascular disease, and benefits appeared early, before substantial weight loss had occurred
Morello, Pharm D, CDE, FCSHP, FASHP, Associate Dean for Student Affairs and Professor of Clinical Pharmacy at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, Clinical Pharmacist Specialist at VASDHS